Gao, Fiona, Regulatory Framework of Drug Entry to China, in: Life Sciences Law, Chapter 6, pages 304 – 308, ISBN: 978-3-03891-025-1
Catégories: China Desk
- Sommaire
- Savoir-faire
- Publications et présentations
- Regulatory Framework of Drug Entry to China
Regulatory Framework of Drug Entry to China
- Voir le document complet (741 kB)
Connaissances connexes
-
Polyphor erteilt Fosun Pharma Exklusivlizenz für Balixafortide in China
Polyphor AG (SIX: POLN) und Shanghai Fosun Pharmaceutical (Group) Co. Ltd. ("Fosun Pharma",...
-
The 3rd Swiss-Chinese Life Sciences Forum 2020 - Session 2
Webinar on Tuesday, July 07, 2020, 10:00 am - 11:00 am Key challenges and collaboration...
-
The 3rd Swiss-Chinese Life Sciences Forum 2020 - Session 1
Webinar on Tuesday, June 30, 2020, 10:00 am - 11:00 am Key challenges and learnings from the...